Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-15

FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie. The approval updates the product under the NDA, potentially affecting labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norvir (ritonavir)

Snippet

SUPPL AP for NORVIR (RITONAVIR)